Commentary

Skin Cancer in Skin of Color [editorial]

Author and Disclosure Information

Differences exist in the epidemiology, clinical presentation, and prognosis of skin cancers in skin of color populations. Among Hispanics and black individuals, detection of skin cancers, including both melanoma and nonmelanoma skin malignancies, often is delayed. As a result, there is a poorer overall prognosis for skin cancers among nonwhites compared to non-Hispanic whites. Factors that likely contribute to the delayed diagnosis of skin cancers in patients with skin of color include decreased access to care, fewer preventative measures, and public and medical misconceptions about who is affected by skin cancer.


 

Recommended Reading

Economic Forecast: Rough Road Ahead for Dermatologists
MDedge Dermatology
RUC Predicted to Slash AK Reimbursement
MDedge Dermatology
AAD Unveils SPOT Program: The Skinny Podcast
MDedge Dermatology
Cancer Diagnosis Appears to Raise Suicide, Cardiovascular Risks
MDedge Dermatology
Cyclops Lambs Played Important Role in Vismodegib's Approval
MDedge Dermatology
Gains in Melanoma Survival Attributed to Patient Awareness
MDedge Dermatology
Total Body Exam Reduces Melanoma Mortality
MDedge Dermatology
Early Detection of Melanoma: Harnessing Untapped Resources
MDedge Dermatology
New Dermoscopic Insights Gleaned for Mucosal Lesions
MDedge Dermatology
Women 30% More Likely to Survive Melanoma Than Men
MDedge Dermatology